FACULTY
Boosting Adherence and Managing Antiretroviral Drug Adverse Events: The Role of the Community Pharmacist
Web-based Activity
Activity Date: June 2008  — Activity Info: Volume 5, (4)
Goals & Objectives | Faculty | Complete Pre-Test Activity | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

 

Full Disclosure Policy Affecting CE Activities:
As a sponsor accredited by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Course Director and Participating Faculty reported the following:

COURSE DIRECTOR

Camille Thornton, PharmD
Clinical Pharmacist-HIV/AIDS
Associate Professor
University of Tennessee
Memphis, Tennessee
Dr Thornton reports receiving honoraria from and serving on the speakers bureau for Bristol-Myers Squibb Company, Gilead Sciences, Inc, GlaxoSmithKline, and Tibotec.

PARTICIPATING FACULTY

Jennifer Cocohoba, PharmD
Health Sciences Assistant Clinical Professor of Pharmacy
University of California, San Francisco
School of Pharmacy
San Francisco, California
Dr Cocohoba reports having no financial or advisory relationships with corporate organizations related to this activity.

Angela D.M. Kashuba, PharmD, DABCP
Associate Professor of Pharmacy
University of North Carolina-Chapel Hill
Director, Clinical Pharmacology and Analytical Chemistry Core
University of North Carolina Center for AIDS Research
Chapel Hill, North Carolina
Dr Kashuba reports receiving grant support from Abbott Laboratories, Bristol-Myers Squibb Company, Gilead Sciences, Inc, Pfizer Inc, and Tibotec.

Jean C. Lee, PharmD, BCPS
Clinical Pharmacist-HIV/AIDS
McAuley Health Center
Grand Rapids, Michigan
Dr Lee reports serving on the speakers' bureau/receiving honoraria from Bristol-Myers Squibb Company, Gilead Sciences, Inc, GlaxoSmithKline, and Roche Pharmaceuticals.


Notice: In accordance with ACPE Criteria for Quality, the audience is advised that all faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.

University of Tennessee Advanced Studies in Pharmacy provides disclosure information from contributing authors, lead presenters, and participating faculty. University of Tennessee Advanced Studies in Pharmacy does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?